SignatureFD’s Serina Therapeutics SER Stock Holding History

SignatureFD’s Portfolio SER Stock Details SER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-71	Closed	-$2K	–	2693
2020 Q1	$2K	Hold	71	–	–	﹤0.01%	2022
2019 Q4	$5K	Buy	+71	New	+$3.83K	﹤0.01%	1652

Other funds holding SER

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

SignatureFD's SER Position: Q2 2020 in Review

SignatureFD sold out of Serina Therapeutics (SER) in Q2 2020, closing a stake of 71 shares — an estimated $2K sold.

SignatureFD first reported a position in SER in Q4 2019 and held it in 2 quarters. The position peaked at $5K in Q4 2019. 48 funds tracked by Wall St. Rank hold SER as of Q2 2020.

SignatureFD reported no remaining Serina Therapeutics position as of Q2 2020 after selling out during the quarter.
SignatureFD sold 71 Serina Therapeutics shares in Q2 2020, an estimated $2K.
SignatureFD first reported a position in Serina Therapeutics in Q4 2019 and held it in 2 quarters.
SignatureFD's Serina Therapeutics position peaked at $5K in Q4 2019.
48 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2020.

Based on SignatureFD's 13F filing for Q2 2020, filed 30 Jul 2020.